Stephanie Finnegan joins Cromos™ Pharma as Chief Operating Officer, company looks to expand its North American footprint
Stephanie Finnegan joins Cromos™ Pharma as Chief Operating Officer, company looks to expand its North American footprint PORTLAND, Ore., Dec. 11, 2017 (GLOBE NEWSWIRE) – Cromos™ Pharma, a premier regional contract research organization announced today that Stephanie Finnegan has been appointed as its Chief Operating Officer. Ms. Finnegan will join the company’s US office and will oversee its European and US operations. “We are very excited to see Ms. Finnegan joining our
cromos-pharma-at-the-swiss-biotech-day-in-basel-on-4-may-2017
cromos-pharma-at-the-swiss-biotech-day-in-basel-on-4-may-2017 Meet Cromos™ Pharma’s VP, International Business & Operations, Dr. Gearóid Tuohy in Basel at the Swiss Biotech Day on 4 May and find out how Cromos™ Pharma can assist you in your clinical drug development programmes. The Swiss Biotech Day is the leading biotechnology conference in Switzerland. This event will bring together more than 500
Cromos™ Pharma has published a white paper on the new EU clinical trial regulation (no. 536/2014) and investigator-led studies
Cromos™ Pharma has published a white paper on the new EU clinical trial regulation (no. 536/2014) and investigator-led studies We are glad to share with you our new white paper by Cromos™ Pharma’s VP, International Business & Operations Dr. Gearóid Tuohy regarding a new Clinical Trial Regulation (Regulation [EU] No 536/2014), scheduled for application this year, and its potential impact on the current imbalances in clinical trials. Please follow the link link to the

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us